Jove
Visualize
Contact Us

Related Experiment Videos

T lineage differentiation from human embryonic stem cells.

Zoran Galic1, Scott G Kitchen, Amelia Kacena

  • 1Department of Medicine, UCLA AIDS Institute, David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1678, USA.

Proceedings of the National Academy of Sciences of the United States of America
|July 18, 2006
PubMed
Summary

Genetically engineered human embryonic stem cells (hESC) can develop into T lymphoid cells. This breakthrough offers potential for treating T cell disorders using stem cell therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling HIV infection, treatment, rebound, and intervention in human immune organoids.

bioRxiv : the preprint server for biology·2026
Same author

NK Cells Engineered with a Chimeric Antigen Receptor Delay HIV Rebound and Reshape HIV Reservoir Composition.

bioRxiv : the preprint server for biology·2026
Same author

CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming.

Trends in biotechnology·2026
Same author

Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns.

Nature communications·2025
Same author

Evaluation of a Rapid Immunoassay for Molecular Subphenotype Classification in Pediatric Acute Cardiorespiratory Failure.

Research square·2025
Same author

A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioning.

Nature communications·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Stem cell biology
  • Immunology
  • Genetic engineering

Background:

  • Human embryonic stem cells (hESC) hold potential for regenerative medicine.
  • Demonstrating hESC differentiation into all hematopoietic lineages remains a challenge.

Purpose of the Study:

  • To investigate the potential of genetically manipulated hESC to differentiate into the T lymphoid lineage.
  • To assess the feasibility of using genetically modified hESC for treating T cell disorders.

Main Methods:

  • Sequential in vitro coculture of hESC on murine bone marrow stromal cells.
  • Engraftment of differentiated cells into human thymic tissues in immunodeficient mice.
  • Monitoring stable transgene expression throughout the differentiation process.

Related Experiment Videos

Main Results:

  • Genetically manipulated hESC successfully differentiated into the T lymphoid lineage.
  • Stable and high-level transgene expression was observed throughout differentiation.
  • This demonstrates a viable pathway for generating functional T cells from engineered hESC.

Conclusions:

  • Genetically modified hESC can differentiate into T lymphoid cells.
  • This approach shows promise for developing novel cell-based therapies for T cell disorders.
  • Further research can explore the therapeutic applications of these engineered stem cells.